DOI
https://doi.org/10.25772/BG79-S858
Author ORCID Identifier
0000-0002-6503-9294
Defense Date
2021
Document Type
Dissertation
Degree Name
Doctor of Philosophy
Department
Nanoscience and Nanotechnology
First Advisor
Jason Reed, PhD
Second Advisor
Joshua Harrell, PhD
Third Advisor
Loren Picco, PhD
Fourth Advisor
Amir Toor, MD
Fifth Advisor
Ross Mikkelsen, PhD
Abstract
Single cell mass is tightly regulated throughout generations and the cell cycle, making it an important marker of cell health. Abnormal changes in cell size can be the first indication of dysfunction in response to environmental stimuli such as cytotoxic drugs. Described here is the further development of high-speed live cell interferometry (HSLCI) to concurrently measure the changes in single cell mass of thousands of cells over time. Critically, the high-throughput nature of HSLCI provides realistic pictures of tumor heterogeneity. This throughput enabled HSLCI to correctly predict in vivo carboplatin sensitivity of three triple negative breast cancer patient derived xenografts, while also characterizing the spectrum of drug response from apoptosis to senescence to drug resistance. HSLCI quantified previous qualitative observations of increases in cell size and losses in cell density in senescent cells, and importantly observed proliferative recovery in cells demonstrating thee senescent characteristics. Furthermore, the addition of a micropipette system has enabled the isolation of rare (~1%) drug resistant cells for further study with molecular biology methods. Together, this work highlights HSLCI’s versatility and potential for clinical, translational, and basic research.
Rights
© Graeme Murray
Is Part Of
VCU University Archives
Is Part Of
VCU Theses and Dissertations
Date of Submission
7-5-2021
Included in
Diagnosis Commons, Nanomedicine Commons, Optics Commons, Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons